Intelligence · Clinical Pipeline
LIGAND PHARMACEUTICALS Pipeline
All ClinicalTrials.gov programs at LIGAND PHARMACEUTICALS — phase, modality, and trial IDs.
- Programs
- 7
Quick answer
LIGAND PHARMACEUTICALS has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Bexarotene (Targretin®)
LIGAND PHARMACEUTICALS INC
Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)
1 trial -
LGD-6972
LIGAND PHARMACEUTICALS INC
Type 2 Diabetes Mellitus
2 trials -
LGD-6972 Solution
LIGAND PHARMACEUTICALS INC
Type 2 Diabetes Mellitus (T2DM)
1 trial -
NCO-48 Fumarate
LIGAND PHARMACEUTICALS INC
Hepatitis B
1 trial -
NCO-48 Fumarate 4 mg
LIGAND PHARMACEUTICALS INC
Chronic Hepatitis B
1 trial -
Ramipril tablet 10 mg
LIGAND PHARMACEUTICALS INC
Bioequivalence
1 trial -
Ramipril/Hydrochlorothiazide tablet 10 mg/25 mg
LIGAND PHARMACEUTICALS INC
Bioequivalence
1 trial
Frequently asked questions
How many pipeline programs does LIGAND PHARMACEUTICALS have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs